You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our CD82 (CD82) ELISA Kits

Full name:
CD82 Molecule ELISA Kits (CD82)
On are 4 CD82 Molecule (CD82) ELISA Kits from 2 different suppliers available. Additionally we are shipping CD82 Antibodies (174) and CD82 Proteins (10) and many more products for this protein. A total of 198 CD82 products are currently listed.
4F9, AA682076, AL023070, C33, GR15, IA4, KAI1, R2, SAR2, ST6, TSPAN27
list all ELISA KIts Gene Name GeneID UniProt
CD82 12521 P40237
CD82 3732 P27701
CD82 83628  

Show all species

Show all synonyms

CD82 (CD82) ELISA Kits by Reactivity

Select your species

More ELISA Kits for CD82 Interaction Partners

Mouse (Murine) CD82 Molecule (CD82) interaction partners

  1. The CD82 is a functional surface marker of long-term repopulating hematopoietic stem cells (LT-HSCs) that maintains quiescence through interaction with DARC (show DARC ELISA Kits)-expressing macrophages in the bone marrow stem cell niche.

  2. The perturbation of CD82-ganglioside-CD44 (show CD44 ELISA Kits) signaling attenuates pathological angiogenesis.

  3. Loss of Kai1 expression is associated with neoplasm metastasis.

  4. The synergistic effects of CD82 and GM3 (show GRM6 ELISA Kits) or GM2 (show CYB5D2 ELISA Kits)/GM3 (show GRM6 ELISA Kits) ganglioside on EGFR (show EGFR ELISA Kits) expression and phosphorylation and cMet activation are responsible for CD82 inhibition of EGF (show EGF ELISA Kits)- and HGF (show HGF ELISA Kits)-dependent cell motility and migration of Hepa1-6 cells.

  5. CD81 (show CD81 ELISA Kits) promotes the microvillus formation and/or extension while tetraspanin CD82 inhibits these events. In addition, CD81 (show CD81 ELISA Kits) enhances the outward bending of the plasma membrane while CD82 inhibits it.

  6. the CD82 tetraspanin is specifically recruited to pathogen-containing phagosomes prior to fusion with lysosomes.

  7. KAI1 has a role in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase

  8. Hypoxia-dependent induction of KAI1 was directly mediated by hypoxia-inducible factor-1alpha binding on the promoter, which subsequently caused increased recruitment of RNA polymerase II for transcriptional activation.

  9. An antibody to this protein that can specifically detect murine Kai1/CD82, should be useful in addressing the mechanism of action of Kai1 in metastatic suppression.

  10. gp78 (show AMFR ELISA Kits) promotes sarcoma metastasis by targeting KAI1 for degradation

Human CD82 Molecule (CD82) interaction partners

  1. The overexpression of KAI1/CD82 inhibited the proliferation and invasion of OSCC-15 cells.

  2. Our present work therefore suggests that CD82 on EC is a potential target for anti-angiogenic therapy in VEGFR2 (show KDR ELISA Kits)-dependent tumor angiogenesis.

  3. that a loss of KAI1/CD82 and an increase in PDGFR (show PDGFRB ELISA Kits) expression in gliomas relate to a progressive tumor growth

  4. KAI1 underexpression is associated with gastric cancer.

  5. KAI1-induced decreases in VEGFC (show VEGFC ELISA Kits) expression are mediated via Src (show SRC ELISA Kits)/STAT3 (show STAT3 ELISA Kits) signaling pathways in pancreatic cancer cells.

  6. The simultaneous overexpression of p12CDK2-AP1 (show FOSB ELISA Kits) and CD82 significantly suppressed the in vivo tumor growth.

  7. Lack of expression of the KAI1 might indicate a more aggressive form of breast cancer.

  8. KAI1 and KISS1 (show KISS1 ELISA Kits) are implicated in the pathogenesis and maintenance of endometriosis.

  9. Ubiquitously expressed CD82 restrains cell migration and cell invasion by modulating both cell-matrix and cell-cell adhesiveness and confining outside-in pro-motility signaling.

  10. Survivin (show BIRC5 ELISA Kits), Bcl-2 (show BCL2 ELISA Kits), and KAI1 are metastasis-related factors in cervical cancer. Overexpression of survivin (show BIRC5 ELISA Kits) and Bcl-2 (show BCL2 ELISA Kits), and low expression of KAI1 promotes cervical cancer progress and metastasis.

CD82 Antigen Profile

Antigen Summary

This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.

Alternative names and synonyms associated with CD82

  • CD82 antigen (Cd82) Elisa Kit
  • CD82 molecule (CD82) Elisa Kit
  • Cd82 molecule (Cd82) Elisa Kit
  • 4F9 Elisa Kit
  • AA682076 Elisa Kit
  • AL023070 Elisa Kit
  • C33 Elisa Kit
  • GR15 Elisa Kit
  • IA4 Elisa Kit
  • KAI1 Elisa Kit
  • R2 Elisa Kit
  • SAR2 Elisa Kit
  • ST6 Elisa Kit
  • TSPAN27 Elisa Kit

Protein level used designations for CD82 Molecule (CD82) ELISA Kits

C33 antigen , inducible membrane protein R2 , kangai 1 (suppression of tumorigenicity 6, prostate) , metastasis suppressor Kangai-1 homolog , CD82 antigen , kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) , metastasis suppressor Kangai-1 , tetraspanin-27 , tspan-27 , CD82 antigen (R2 leukocyte antigen antigen detected by monoclonal and antibody IA4)) , CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) , Kangai 1 (suppression of tumerigenicity 6 prostate) CD82 antigen , Kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) , kangai 1 (suppression of tumorigenicity 6), prostate

12521 Mus musculus
3732 Homo sapiens
83628 Rattus norvegicus
Selected quality suppliers for CD82 (CD82) ELISA Kits
Did you look for something else?